Document is current
Any future updates will be listed below
-
Authors
Chiappa, Valentina
Interlenghi, Matteo
Bogani, Giorgio
Salvatore, Christian https://orcid.org/0000-0001-9312-4675
Bertolina, Francesca
Sarpietro, Giuseppe
Signorelli, Mauro
Ronzulli, Dominique
Castiglioni, Isabella
Raspagliesi, Francesco
- License Information
-
More Information
Article History
Received: 6 May 2021
Accepted: 21 May 2021
First Online: 26 July 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.Patients in the prospective cohort and patients still alive and traceable in the retrospective cohort signed the study-specific informed consent. For deceased or untraceable patients, the Principal Investigator has filled in the “Replacement form for informed consent” approved by the ethics committee, in compliance with DGPR 679/2016
: Not applicable.
: Isabella Castiglioni and Matteo Interlenghi own DeepTrace Technologies S.R.L shares. Christian Salvatore is the CEO of DeepTrace Technologies S.R.L. DeepTrace Technologies. S.R.L is a spin-off of Scuola Universitaria degli Studi Superiori IUSS, Pavia, Italy. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
